Roger Prichard
10Patents
3h-index
13Co-inventors
57Inventor score
Filing activity: Apr 28, 1998 → Jul 29, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6114376A | Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells | Human Necessities | 17 | Expired |
| US6593087B2 | Methods for detecting and reversing resistance to macrocyclic lactone compounds | Human Necessities | 6 | Expired |
| US10000811B2 | Markers to predict macrocyclic lactone drug resistance in dirofilaria immitis, the causative agent of heartworm disease | Chemistry; Metallurgy | 3 | Active |
| US6403308B1 | Methods for detecting and reversing resistance to macrocyclic lactone compounds | Human Necessities | 1 | Expired |
| US11021508B2 | Use of avermectin derivative for increasing bioavailability and efficacy of macrocyclic lactones | Chemistry; Metallurgy | 0 | Active |
| US11130776B2 | Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones | Chemistry; Metallurgy | 0 | Active |
| US11414703B2 | Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, the causative agent of heartworm disease | Chemistry; Metallurgy | 0 | Active |
| US12391991B2 | Markers to predict macrocyclic lactone drug resistance in Dirofilaria immitis, the causative agent of heartworm disease | Chemistry; Metallurgy | 0 | Active |
| US8722332B2 | Macrocyclic lactone resistance marker for dirofilaria immitis | Chemistry; Metallurgy | 0 | Active |
| US7358053B2 | Methods for detecting and reversing resistance to macrocyclic lactone compounds | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.